Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions
暂无分享,去创建一个
G. Tonini | P. Scaruffi | P. Castagnola | W. Giaretti | S. Gandolfo | M. Pentenero | S. Coco | R. Mariño | U. Familiari | D. Malacarne | A. Donadini | M. Maffei | E. Di Nallo | E. D. Nallo
[1] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[2] Xiaoya Yang,et al. Decoy receptor 3 expression in esophageal squamous cell carcinoma: correlation with tumour invasion and metastasis , 2011, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[3] P. Lansdorp,et al. RTEL1: an essential helicase for telomere maintenance and the regulation of homologous recombination , 2010, Nucleic acids research.
[4] M. Scala,et al. Oral Cancer Genesis and Progression: DNA Near-Diploid Aneuploidization and Endoreduplication by High Resolution Flow Cytometry , 2010, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[5] E. Birney,et al. A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.
[6] W. Giaretti,et al. DNA aneuploidy and dysplasia in oral potentially malignant disorders: association with cigarette smoking and site. , 2009, Oral oncology.
[7] R. Botella-Estrada,et al. [Oral leukoplakia: clinical, histopathologic, and molecular features and therapeutic approach]. , 2009, Actas dermo-sifiliograficas.
[8] R. Botella-Estrada,et al. La leucoplasia oral: definición de parámetros clínicos, histopatológicos y moleculares y actitud terapéutica , 2009 .
[9] Niko Beerenwinkel,et al. Construction of oncogenetic tree models reveals multiple pathways of oral cancer progression , 2009, International journal of cancer.
[10] Stephen C. West,et al. RTEL1 Maintains Genomic Stability by Suppressing Homologous Recombination , 2008, Cell.
[11] C. R. Leemans,et al. Comparative evaluation of genetic assays to identify oral pre-cancerous fields. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[12] C. Scully,et al. Oral potentially malignant lesions: first-level micro-histological diagnosis from tissue fragments sampled in liquid-based diagnostic cytology. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[13] G. de Rosa,et al. Prognostic value of human telomerase reverse transcriptase gene expression in oral carcinogenesis. , 2007, International journal of oncology.
[14] G. Dakubo,et al. Clinical implications and utility of field cancerization , 2007, Cancer Cell International.
[15] T. Axéll,et al. Management of oral epithelial dysplasia: a review. , 2007, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[16] G. Lodi,et al. Interventions for treating oral leukoplakia. , 2006, The Cochrane database of systematic reviews.
[17] Shu-Chun Lin,et al. Array‐comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas , 2006, Molecular carcinogenesis.
[18] T. Furuya,et al. Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways , 2006, The Journal of pathology.
[19] P J F Snijders,et al. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus , 2006, Oncogene.
[20] D. Trisciuoglio,et al. Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function , 2005, Cell Death and Differentiation.
[21] Han-Woong Lee,et al. The pleiotropy of telomerase against cell death. , 2005, Molecules and cells.
[22] J. Fridlyand,et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma , 2005, Oncogene.
[23] C. R. Leemans,et al. A genetic progression model of oral cancer: current evidence and clinical implications. , 2004, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[24] D. Albertson,et al. Chromosome aberrations in solid tumors , 2003, Nature Genetics.
[25] C. R. Leemans,et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.
[26] S. Kamel‐Reid,et al. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis , 2002, Head & neck.
[27] C. R. Leemans,et al. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. , 2002, Head & neck.
[28] G. Snow,et al. Second primary tumors and field cancerization in oral and oropharyngeal cancer: Molecular techniques provide new insights and definitions , 2002 .
[29] C. R. Leemans,et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[30] S. Gollin. Chromosomal alterations in squamous cell carcinomas of the head and neck: Window to the biology of disease , 2001, Head & neck.
[31] R. Brakenhoff,et al. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[32] T. Liehr,et al. Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridisation. , 1998, Oral oncology.
[33] A. Huvos,et al. Molecular support for field cancerization in the head and neck , 1998, Cancer.
[34] W. Giaretti,et al. Consensus Report of the Task Force on Standardisation of DNA Flow Cytometry in Clinical Pathology , 1998, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.
[35] G. Snow,et al. Biologic implications of genetic changes in head and neck squamous cell carcinogenesis. , 1997, The Australian and New Zealand journal of surgery.
[36] S. Piantadosi,et al. Poster 7: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996, Cancer research.
[37] J. Califano,et al. 11:40 AM: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996 .
[38] W. Giaretti. A model of DNA aneuploidization and evolution in colorectal cancer. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[39] F. Bosch,et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. , 1993, Cancer research.
[40] W. Hong,et al. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. , 1993, Cancer research.
[41] D. Slaughter,et al. “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.
[42] K Davidson,et al. TOBACCO-SMOKING , 1889, Science.
[43] I. Tohnai,et al. Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[44] I. van der Waal,et al. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. , 2009, Oral oncology.
[45] G. Collins. The next generation. , 2006, Scientific American.
[46] L. Barnes,et al. Pathology and genetics of head and neck tumours , 2005 .
[47] M. Thun,et al. Tobacco smoke and involuntary smoking. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.
[48] F J Otto,et al. High-resolution analysis of nuclear DNA employing the fluorochrome DAPI. , 1994, Methods in cell biology.
[49] S. Taylor. Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.
[50] Robert C. Wolpert,et al. A Review of the , 1985 .